BTLA/CD272 Rekombinanter Antikörper
BTLA/CD272 Rekombinant Antikörper für FC, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
FC, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
241318H5
Kat-Nr. : 98096-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
98096-1-PBS bindet in FC, Indirect ELISA BTLA/CD272 und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | Rekombinantes Protein |
| Vollständiger Name | B and T lymphocyte associated |
| Berechnetes Molekulargewicht | 289 aa, 33 kDa |
| GenBank-Zugangsnummer | BC107091 |
| Gene symbol | BTLA |
| Gene ID (NCBI) | 151888 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein A purfication |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. |
Hintergrundinformationen
BTLA ( B and T lymphocyte attenuator), also known as CD272, is a member of the CD28 superfamily and is a type I membrane glycoprotein identified as an inhibitory receptor (PMID: 33859648). BTLA is extensively expressed in lymph nodes, thymus, and spleen, with little or no expression in organs such as the heart, kidney, brain, and liver (PMID: 33859648). Among immune cells, BTLA is primarily expressed in B and T cells, with higher expression in B cells compared to T cells in the mouse spleen (PMID: 33859648). BTLA plays a crucial role in regulating stimulatory and inhibitory signals in immune responses.





